Teva Pharmaceutical Industries (TEVA) Payout Ratio (2009 - 2018)

Teva Pharmaceutical Industries (TEVA) has reported Payout Ratio for 10 consecutive years, with 0.01 the latest figure, recorded in Q1 2018.

• For the quarter ending Q1 2018, Payout Ratio fell 98.09% year-over-year to 0.01; the trailing twelve-month figure through Dec 2018 stood at 0.01 (up 90.83% YoY), and the FY2018 full-year result was 0.01, up 90.83% from the prior year.
• Payout Ratio advanced to 0.01 in Q1 2018 per TEVA's latest filing, from 0.01 in the prior quarter.
• Across five years, Payout Ratio topped out at 2.79 in Q3 2015 and bottomed at 0.33 in Q4 2016.
• Historically, Payout Ratio has averaged 0.6 across 5 years, with a median of 0.53 in 2015.
• The sharpest annual moves came in 2015 and 2016: Payout Ratio soared 722.65% in 2015, then plunged 155.75% in 2016.
• Over 5 years, Payout Ratio stood at 0.87 in 2014, then slumped by 31.19% to 0.6 in 2015, then slumped by 155.75% to 0.33 in 2016, then soared by 97.75% to 0.01 in 2017, then surged by 251.66% to 0.01 in 2018.
• According to Business Quant data, Payout Ratio over the past three periods registered 0.01, 0.01, and 0.23 for Q1 2018, Q4 2017, and Q3 2017 respectively.